20–40%
longer mean lifespan, and fewer tumors, in rodent studies
Longevity
Source: Peptilex study tracker (weekly review)
20–40%
longer mean lifespan, and fewer tumors, in rodent studies
2025
independent confirmation that it lengthens telomeres in human cells
Rodent studies linked it to 20–40% longer mean lifespan and fewer tumors, and an independent group confirmed in 2025 that it lengthens telomeres in human cells. Registered human trials are the next step.
Go deeper
What it is, how it acts, the key studies, risks and open questions.

Source: PubMed and ClinicalTrials.gov via the Peptilex study database
ClinicalTrials.gov · name in study title · ongoing first
No registered trial yet on ClinicalTrials.gov.
PubMed · newest first
Lab studyAl-Dulaimi S et al. · BiogerontologyPMID 40908429
Lab studyGatta M et al. · Stem Cell Reviews and ReportsPMID 40493162
Overview of Epitalon-Highly Bioactive Pineal Tetrapeptide with Promising Properties
ReviewAraj SK et al. · International Journal of Molecular SciencesPMID 40141333
Lab studyUllah S et al. · Life SciencesPMID 39788414
Epitalon protects against post-ovulatory aging-related damage of mouse oocytes in vitro
Lab studyYue X et al. · AgingPMID 35413689
Effect of the synthetic pineal peptide epitalon on spontaneous carcinogenesis in female C3H/He mice
Animal studyKossoy G et al. · In VivoPMID 16634527
Animal studyAnisimov VN et al. · Voprosy OnkologiiPMID 15909815
Animal studyAnisimov VN et al. · Bulletin of Experimental Biology and MedicinePMID 12459848